**Core Concept**
Chromophilic renal cell carcinoma (RCC), also known as papillary RCC, is a subtype of kidney cancer with distinct cytogenetic and molecular characteristics. This cancer type arises from the proximal convoluted tubules of the kidney and is associated with specific genetic alterations.

**Why the Correct Answer is Right**
The cytogenetics of chromophilic RCC is characterized by the presence of trisomy 7 and trisomy 17, which are whole chromosome gains. These genetic alterations are thought to contribute to the development and progression of the disease. Additionally, chromophilic RCC often harbors mutations in the MET gene, which encodes a receptor tyrosine kinase involved in cell growth and proliferation.

**Why Each Wrong Option is Incorrect**
* **Option A:** This option is incorrect because chromophilic RCC is not typically associated with the ETV6-NTRK3 fusion gene, which is more commonly found in papillary thyroid carcinoma.
* **Option B:** This option is incorrect because chromophilic RCC does not typically exhibit the t(11;22) translocation, which is characteristic of Ewing's sarcoma.
* **Option C:** This option is incorrect because chromophilic RCC does not typically involve the PAX8-PPARγ fusion gene, which is more commonly found in follicular thyroid carcinoma.

**Clinical Pearl / High-Yield Fact**
Chromophilic RCC is often associated with a better prognosis compared to other subtypes of RCC, and surgical resection is the primary treatment option. However, patients with advanced disease may benefit from targeted therapies, such as tyrosine kinase inhibitors, which can inhibit the MET pathway.

**Correct Answer: C. Trisomy 7 and trisomy 17.**